Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study
International Archives of Allergy and Immunology · 2024
DOI: 10.1159/000534662 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Qiquan Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Southwest Hospital, Amy Medical University, Chongqing, China, chenqq0548@163.com. Hauptthemen laut MEDLINE: Chronic Urticaria, Urticaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Chronic spontaneous urticaria (CSU) with autoreactivity is often resistant to antihistamines. Autologous whole blood injection (AWBI) has shown potential efficacy in the treatment of this disease, but it is controversial. It is necessary to screen patients who are suitable for this therapy in advance. This study aimed to identify biomarkers that predict the efficacy of AWBI treatment in CSU patients with autoreactivity.
Methods
A total of 30 patients with autologous serum skin test-positive CSU treated with AWBI were included in this study; urticaria activity score (UAS7) was recorded and the treatment response was judged based on it. Levels of total serum IgE, anti-high-affinity IgE receptor (FcεRI) IgG, and basophils CD63 and FcεRI expressions, and D-dimer of all patients were determined and analyzed.
Results
Baseline levels of total IgE, D-dimer, basophil FcεRI and CD63 expressions showed good correlations with UAS7 variations. D-dimer, basophil FcεRI and CD63 expressions changed significantly before and after AWBI treatment in AWBI responders, and the basophil FcεRI and CD63 expressions consistently and dynamically decreased in AWBI responders during the treatment. Baseline levels of total IgE, D-dimer, basophil FcεRI and CD63 expressions showed certain predictive values for AWBI response.
Conclusions
Baseline levels of total IgE, D-dimer, basophil FcεRI and CD63 expressions could be biomarkers of predicting AWBI efficacy in patients with CSU with autoreactivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Southwest Hospital, Amy Medical University, Chongqing, China, chenqq0548@163.com.
- Department of Dermatology, The 75th Group Army Hospital, Dali, China.
- Department of Dermatology, Southwest Hospital, Amy Medical University, Chongqing, China.
- Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
- Center for Research and Development, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, China.
Zitieren
APA
Chen, Q., Luo, J., Yang, X., Chen, W., Liu, W., & Song, Z. (2024). Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study. International Archives of Allergy and Immunology. https://doi.org/10.1159/000534662
Vancouver
Chen Q, Luo J, Yang X, Chen W, Liu W, Song Z. Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study. International Archives of Allergy and Immunology. 2024. doi:10.1159/000534662
BibTeX
@article{Chen2024,
author = {Chen, Qiquan and Luo, Jincheng and Yang, Xianjie and Chen, WenChieh and Liu, Wenying and Song, Zhiqiang},
title = {Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study},
journal = {International Archives of Allergy and Immunology},
year = {2024},
doi = {10.1159/000534662}
}
EUVIMED